Navigation Links
Increase in HIV Cases Due To Restricted Offering of the Preventive Treatment

It was claimed that hundreds and thousands of people have contracted HIV because they were not been prescribed a preventive treatment. //

A man who called himself Robert told publicly in the BBC radio 4 law in action programme that the preventive treatment post exposure prophylaxis (PEP) was not widely available in the market and hence this led to the spread of HIV. He also said that he is seeking a judicial review of government policy on PEP.

But on the other hand the department of health rejected his claims by saying that there has been a large amount of information campaigns about PEP and guidelines. It was also said that the therapy was available to all in need. This therapy contains a cocktail of drugs costing about 600 to 1000 pounds. If administered soon after exposure it is thought to be highly effective in preventing an individual contracting HIV. It is mainly given to health professionals who have been accidentally exposed to HIV.

This man was infected with HIV when the condom he was using broke and unknowingly infected another man. He said that he was not aware of PEP and has discovered its existence only now. He said that he was very furious that the treatment was not prescribed to him.

To his comment the department of health officials said that it had funded the Terrace Higgins trust to raise awareness of PEP among gay men. It had featured targeted advertisements in the gay press and leaflets and distributed in gay bars.

Dr. Trevor Stammers an expert on sexual health and vice chairman of the Christian medical fellowship said that a large number of people are repeatedly practising unsafe sex which led to the increase in the HIV cases.

If PEP were held in every casualty department and given out liberally then it was predicted that five years ago it would have worsened the problems of sexually transmitted infection.


'"/>




Page: 1

Related medicine news :

1. Use of Cellular Phones associated with Increased risk of Brain Tumors
2. Increase in sugar...decrease in brain function!!!
3. Increase in tobacco deaths
4. Increased Heart Attack Risk From Celebrex,Vioxx
5. Deep Sleep Doesnt Increase Memory
6. Allergy Risk Increased by Kerosene Use
7. IVF technique May Increase The Risk Of Birth Defects
8. Step Aerobics Increases good cholesterol
9. Increase in renal problems
10. Fewer teeth & Increased Ischemic Stroke risk
11. Painkillers Increase Risk of Miscarriage
Post Your Comments:
(Date:5/23/2012)... research suggests that young asthma patients who use drugs ... -- could be more likely than others to suffer ... increased risk was not seen for some types of ... the recent interest in use of anticholinergics in asthma," ... at Chicago, said in a news release from the ...
(Date:5/23/2012)... viral infections during infancy is not associated with wheezing ... researchers in the Netherlands. While viral illnesses with wheezing ... was due in part to decreased neonatal lung function. ... thought to be a risk factor for later asthma ... due to the viruses themselves or whether rhinovirus-associated wheeze ...
(Date:5/23/2012)... FRANCISCO Researchers in the United Kingdom have ... has anti-inflammatory properties, can be an effective treatment ... (BOS), a life-threatening complication that occurs in the ... BOS is the leading cause of mortality after ... part when the body repeatedly rejects the transplanted ...
(Date:5/22/2012)... Bend Research Inc., a leading independent ... expansion of its existing hot-melt extrusion (HME) ... Leistritz twin-screw mixer/extruder. , The 18mm ... 27mm Leistritz and 19mm Baker Perkins extruder ... high-shear wet-granulation capabilities. Many projects have been ...
(Date:5/22/2012)... HealthDay Reporter , , TUESDAY, May 22 (HealthDay ... apnea, a common cause of snoring and daytime sleepiness, ... associated with the condition -- the risk of developing ... number of new cases of high blood pressure in ... airway pressure therapy, or CPAP, for either about four ...
Breaking Medicine News(10 mins):Health News:Asthma Meds May Be Linked to Irregular Heartbeat 2Health News:Viral infections in infancy are not associated with wheezing symptoms in later childhood 2Health News:Study shows antibiotic improves respiratory function in lung transplant patients 2Health News:Sleep Apnea 'Mask' Might Also Help the Heart 2Health News:Sleep Apnea 'Mask' Might Also Help the Heart 3Health News:Sleep Apnea 'Mask' Might Also Help the Heart 4
... Year-to-date, NANJING, China, Nov. 5 /Xinhua-PRNewswire-FirstCall/ -- ... manufacturer and supplier of,branded generic pharmaceuticals and manufacturer ... today reported unaudited,financial results for the quarter ended ... -- Total revenue increased to RMB323.4 million ...
... Genelabs,Technologies, Inc. (Nasdaq: GNLB ) announced today ... at the Acumen BioFin Rodman & Renshaw,9th Annual ... am,Eastern Time. The webcast can be accessed through ... at http://www.Genelabs.com . About Genelabs Technologies ...
... Nov. 5 Cardinal Health, a,global provider of ... of health care, announced that effective today, Mark ... officer of the company,s,Healthcare Supply Chain Services (HSCS) ... W. Henderson, 42, will assume the,additional role of ...
... Data Indicate New HspE7 Promotes More Potent ... 5 /PRNewswire-FirstCall/ - Nventa,Biopharmaceuticals Corporation (TSX:NVN) today ... the 24th International Papillomavirus,conference, the largest annual ... the field of human papillomavirus (HPV), taking ...
... FRANCISCO, Calif., Nov. 5 OTN, a leading,physician ... of products,and services to the community physician market, ... community-based practices, today,announced that Oncology Physician Resource (OPR) ... for another year. Under the extended,agreement, which is ...
... Nov. 5 HealthCoach,( http://www.healthcoach.net ) is pleased ... as Vice President of Consulting. James will drive ... the,adoption of healthy lifestyle habits for both by ... the overall development of,the HealthCoach corporate service offerings. ...
Other Medicine News:Health News:Simcere Pharmaceutical Group Reports Third Quarter 2007 Results 2Health News:Simcere Pharmaceutical Group Reports Third Quarter 2007 Results 3Health News:Simcere Pharmaceutical Group Reports Third Quarter 2007 Results 4Health News:Simcere Pharmaceutical Group Reports Third Quarter 2007 Results 5Health News:Simcere Pharmaceutical Group Reports Third Quarter 2007 Results 6Health News:Simcere Pharmaceutical Group Reports Third Quarter 2007 Results 7Health News:Simcere Pharmaceutical Group Reports Third Quarter 2007 Results 8Health News:Simcere Pharmaceutical Group Reports Third Quarter 2007 Results 9Health News:Simcere Pharmaceutical Group Reports Third Quarter 2007 Results 10Health News:Simcere Pharmaceutical Group Reports Third Quarter 2007 Results 11Health News:Simcere Pharmaceutical Group Reports Third Quarter 2007 Results 12Health News:Simcere Pharmaceutical Group Reports Third Quarter 2007 Results 13Health News:Cardinal Health Announces Sector Management Change 2Health News:Nventa presents HspE7 data at international HPV conference 2Health News:Nventa presents HspE7 data at international HPV conference 3Health News:Nventa presents HspE7 data at international HPV conference 4Health News:Nventa presents HspE7 data at international HPV conference 5Health News:Oncology Physician Resource (OPR) Extends Agreement With OTN and Onmark as Oncology Services Partner 2Health News:Oncology Physician Resource (OPR) Extends Agreement With OTN and Onmark as Oncology Services Partner 3Health News:HealthCoach Welcomes James Herrera as Vice President of Consulting 2
(Date:5/22/2012)... Vanda Pharmaceuticals Inc. (NASDAQ: VNDA ), ... commercialization of products for central nervous system disorders, ... at the Society for Research on Biological Rhythms ... The first poster entitled Pleiomorphic Expression of ... insight into the challenges faced by individuals suffering ...
(Date:5/22/2012)... ALLEGAN, Mich., May 22, 2012  Perrigo Company ... final approval from the U.S. Food and Drug ... for butoconazole nitrate 2% vaginal cream, the generic ... submit a substantially complete ANDA with a paragraph ... marketing exclusivity. Perrigo is working exclusively with KV Pharmaceutical ...
(Date:5/22/2012)... Generics, a division of Prodigy Health Supplier Corporation ... generic equivalent of the branded drug Camptosar by ... Laboratories to develop a portfolio of oncology products. ... developed through the partnership that will add consistent ... market, which has experienced record levels of shortages ...
Breaking Medicine Technology:Vanda Pharmaceuticals Inc. Presents Scientific Posters at Society for Research on Biological Rhythms (SRBR) Annual Meeting 2Vanda Pharmaceuticals Inc. Presents Scientific Posters at Society for Research on Biological Rhythms (SRBR) Annual Meeting 3Perrigo Receives FDA Approval for Butoconazole Nitrate 2% Vaginal Cream 2Perrigo Receives FDA Approval for Butoconazole Nitrate 2% Vaginal Cream 3GeoVax Initiates Third Site For Therapeutic Testing of Its HIV Vaccine 19815 1GeoVax Initiates Third Site For Therapeutic Testing of Its HIV Vaccine 19815 2GeoVax Initiates Third Site For Therapeutic Testing of Its HIV Vaccine 19815 3GeoVax Initiates Third Site For Therapeutic Testing of Its HIV Vaccine 19815 4ULURU Inc Announces the Engagement of Gilford Securities Incorporated to Serve as the Companys Financial Advisor 18324 1ULURU Inc Announces the Engagement of Gilford Securities Incorporated to Serve as the Companys Financial Advisor 18324 2MAP Pharmaceuticals to Present Data on LEVADEX AE at the 15th Congress of the International Headache Society 18320 1MAP Pharmaceuticals to Present Data on LEVADEX AE at the 15th Congress of the International Headache Society 18320 2MAP Pharmaceuticals to Present Data on LEVADEX AE at the 15th Congress of the International Headache Society 18320 3MAP Pharmaceuticals to Present Data on LEVADEX AE at the 15th Congress of the International Headache Society 18320 4
... 22 /PRNewswire-FirstCall/ - Alfacell Corporation,(Nasdaq: ACEL ) ... International,Journal of Oncology (2007; Vol. 31, Issue 3: ... (ROI) in,normal cell types and tumor cell lines. ... to its cytotoxic effect on cancer cells and,mechanistic ...
... Women to Evaluate QuatRx,s ... ANN ARBOR, Mich., Aug. 22 QuatRx Pharmaceuticals, ... compounds to treat endocrine, metabolic and,cardiovascular disorders, today ... Phase 3 clinical trial of Ophena(TM) (ospemifene), the,company,s ...
Other Medicine Technology:Paper in International Journal of Oncology Reports Alfacell's ONCONASE(R) Suppresses Intracellular Oxidative Stress 2Paper in International Journal of Oncology Reports Alfacell's ONCONASE(R) Suppresses Intracellular Oxidative Stress 3QuatRx Completes Patient Enrollment in Phase 3 Study of Ophena(TM) in Women with Postmenopausal Vaginal Syndrome 2QuatRx Completes Patient Enrollment in Phase 3 Study of Ophena(TM) in Women with Postmenopausal Vaginal Syndrome 3
... NGAL (neutrophil gelatinase-associated lipocalin, lipocalin-2) is ... injury, predicting acute renal failure with a ... increased, especially in urine, as early as ... NGAL an ideal diagnostic marker for acute ...
... 253 is an assayed quality control material ... hemoglobin and hemoglobin fractions on CO-Oximeter instrumentation. ... a control that parallels the human physiologic ... 253 is available in three (3) levels ...
... QC 233 is an ... for monitoring the measurements of ... on CO-Oximeter instrumentation. It is ... for monitoring analyzer performance at ...
... 623 is an assayed quality control material for ... in four (4) levels for monitoring analyzer performance ... may be used on multiple test analyzers (such ... Radiometer 600). QC623 is also for use on ...
Medicine Products: